All In MedTech

Device Trial Radar · NCT07845721

Using Contact Lenses and Spectacle Lenses as Myopia Interventions.

Twelve-Month Outcomes in Children Using MiSight® 1-Day Contact Lenses and Myopia Control Spectacle Lenses as Complementary Myopia Control Interventions.

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

58

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Feb 2028

Study completion Feb 2028

Sponsor

Lead sponsor
CooperVision International Limited (CVIL)Not on our public-company list
Sponsor type
Industry
Collaborators
SightGlass Vision, Inc.
First posted
Sep 29, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 11 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Effect of alternating contact lenses and spectacles for myopia control.

Conditions

  • Myopia

Interventions

  • Test Spectacle Lens & Contact LensDevice

    Participants will wear contact lenses for a target of 10 hours a day, 5 days per week and test spectacle lenses for remaining waking hours.

  • Control Spectacle Lens & Contact LensDevice

    Participants will wear contact lenses for a target of 10 hours a day, 5 days per week and control spectacle lenses for remaining waking hours.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in axial length (AXL, mm) over 12 monthsTime frame: Over 12 months

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Centre for Ocular Research & Education (CORE) School of Optometry & Vision Science University of Waterloo

    Waterloo, Ontario, Canada

  • Aston University

    Birmingham, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.